ID: ALA1729272

Max Phase: Preclinical

Molecular Formula: C16H16N2O4S2

Molecular Weight: 364.45

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Cc1cccc(C)c1NC(=O)C1C(=O)c2sccc2N(C)S1(=O)=O

Standard InChI:  InChI=1S/C16H16N2O4S2/c1-9-5-4-6-10(2)12(9)17-16(20)15-13(19)14-11(7-8-23-14)18(3)24(15,21)22/h4-8,15H,1-3H3,(H,17,20)

Standard InChI Key:  YPGZJJDHEDVKFE-UHFFFAOYSA-N

Associated Targets(Human)

Importin subunit alpha-2 14 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 364.45Molecular Weight (Monoisotopic): 364.0551AlogP: 2.33#Rotatable Bonds: 2
Polar Surface Area: 83.55Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 6.66CX Basic pKa: CX LogP: 2.65CX LogD: 1.84
Aromatic Rings: 2Heavy Atoms: 24QED Weighted: 0.83Np Likeness Score: -1.04

References

1. PubChem BioAssay data set, 

Source

Source(1):